Exenatide improves postprandial hyperglycaemia and dyslipidaemia in metformin treated patients with type 2 diabetes

被引：0
|
作者：
Bunck, M. C. [1 ]
Corner, A. [2 ]
Diamant, M. [1 ]
Eliasson, B. [3 ]
Malloy, J. L. [4 ]
Shaginian, R. M. [5 ]
Deng, W. [4 ]
Kendall, D. M. [4 ]
Smith, U. [3 ]
Yki-Jarvinen, H. [2 ]
Heine, R. J. [1 ]
Taskinen, M. R. [2 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, Dept Endocrinol, Amsterdam, Netherlands
[2] Helsinki Univ Hosp, Dept Med, Helsinki, Finland
[3] Sahlgrens Univ Hosp, Lundberg Lab Diabet Res, Gothenburg, Sweden
[4] Amylin Pharmaceut Inc, San Diego, CA USA
[5] Eli Lilly & Co, Nederland, Houten, Netherlands
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
879
引用
收藏
页码：S351 / S351
页数：1
相关论文
共 50 条
  • [41] Metformin enhances secretion of GLP-1 but not GIP and improves postprandial glucose excursion in Japanese patients with type 2 diabetes
    Kuwata, H.
    Yabe, D.
    Sugawara, K.
    Usui, R.
    Sugizaki, K.
    Kitamoto, Y.
    Fujiwara, S.
    Watanabe, K.
    Hyo, T.
    Murakami, T.
    Yamaguchi, T.
    Shimizu, S.
    Eto, H.
    Kurose, T.
    Seino, Y.
    DIABETOLOGIA, 2012, 55 : S97 - S97
  • [42] Safety and efficacy of exenatide in patients with type 2 diabetes mellitus using thiazolidenediones with or without metformin
    Zinman, Bernard
    Hoogwerf, Byron
    Garcia, Santiago Duran
    Milton, Denai
    Giaconia, Joseph
    Kim, Dennis
    Trautmann, Michael
    Brodows, Robert
    DIABETES, 2006, 55 : A28 - A28
  • [43] Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
    Dziegielewska-Gesiak, Sylwia
    Fatyga, Edyta
    Pilot, Magdalena
    Wierzgon, Aleksander
    Muc-Wierzgon, Malgorzata
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 3589 - 3599
  • [44] Exenatide improves acute phase insulin response to a meal in patients with type 2 diabetes
    Han, J.
    Dong, H.
    Nielsen, L.
    Qu, Y.
    Glass, L.
    Bhole, D.
    Maggs, D.
    DIABETOLOGIA, 2008, 51 : S345 - S345
  • [45] One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment
    Bunck, M. C.
    Mari, A.
    Corner, A.
    Eliasson, B.
    Shaginian, R. M.
    Wu, Y.
    Yan, P.
    Heine, R. J.
    Smith, U.
    Taskinen, M. -R.
    Yki-Jarvinen, H.
    Diamant, M.
    DIABETOLOGIA, 2009, 52 : S7 - S7
  • [46] Metformin prevents weight gain and improves cardiovascular outcome in patients with type 2 diabetes intensively treated with insulin
    Kooy, Adriaan
    De Jager, Jolien
    Lehert, Philippe
    Bets, Daniel
    Wulffele, Michiel G.
    Donker, Ab J.
    Stehouwer, Coen D.
    DIABETES, 2007, 56 : A154 - A154
  • [47] Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
    Ohira, Masahiro
    Yamaguchi, Takashi
    Saiki, Atsuhito
    Ban, Noriko
    Kawana, Hidetoshi
    Nagumo, Ayako
    Murano, Takeyoshi
    Shirai, Kohji
    Tatsuno, Ichiro
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 313 - 319
  • [48] Treatment intensification with insulin degludec improves glycaemic control in patients with Type 2 diabetes treated with liraglutide and metformin
    Kumar, S.
    Aroda, V.
    Bailey, T.
    Cariou, B.
    Leiter, L.
    Raskin, P.
    Zacho, J.
    Philis-Tsimikas, A.
    DIABETIC MEDICINE, 2015, 32 : 66 - 66
  • [49] PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH
    Schmidt, W. E.
    Christiansen, J. S.
    Hammer, M.
    Zychma, M. J.
    Buse, J.
    VALUE IN HEALTH, 2009, 12 (03) : A105 - A105
  • [50] Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
    Voukali, Maria
    Kastrinelli, Irene
    Stragalinou, Sapfo
    Tasiopoulou, Dimitra
    Paraskevopoulou, Pinelopi
    Katsilambros, Nicholas
    Kokkinos, Alexandros
    Tentolouris, Nicholas
    Ioannidis, Ioannis
    JOURNAL OF DIABETES RESEARCH, 2014, 2014
12345